Advertisement

Topics

Companies Related to "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" [Most Relevant Company Matches] - Page: 5 RSS

01:27 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" found in our extensive corporate database of over 50,000 company records.

Showing "Trial Maraviroc Combination With Optimized Background Therapy Versus" Companies 101–125 of 2,200+

Probably Relevant

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will complement existing therapies. TRC093 is a monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis...


Dr. Macrene Skin Results

As the Derm-Scientist®, Macrene Alexiades-Armenakas,' M.D., Ph.D., F.A.A.D., esteemed background spanning over 20 years encompasses scientific research and clinical dermatology. The recipient of three Harvard degrees: bachelors of arts (A.B.), medical degree(M.D.) and doctorate(Ph.D.) in genetics, Dr. Macrene has spent years in the laboratory investigating various science fields including plant m...

NightBalance

NightBalance, founded in 2009 and based in The Hague, the Netherlands, developed and markets the Sleep Position Trainer, a proprietary, highly advanced and easy to use device to prevent positional obstructive sleep apnea. CE-marked since 2012, the SPT is currently sold in 11 European countries. NightBalance’s wealth of clinical data supports the efficacy ...


Reprieve Cardiovascular

Reprieve Cardiovascular’s Guided Diuretic Therapy is designed to manage fluids during diuretic therapy for patients with Acute Decompensated Heart Failure (ADHF), and may relieve a number of symptoms related to this condition. The therapy has the potential to enable precise and predictable management of a patient’s fluid levels, guarding against ...

GTX

GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel hormonal therapeutics for cancer and serious conditions related to men’s health. GTx's lead drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. GTx is developing...

ProCure Treatment Centers, Inc.

ProCure Treatment Centers, Inc. is a privately held healthcare company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. The company was founded in 2005 in Bloomington, Ind., and is the first to develop a network of proton therapy centers in cities across the United States. The ProCure Proton Therapy Center in...

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. Launched by Fidelity Biosciences in 2013, the Dimension team comprises biotech industry veterans and renowned thought leaders in gene therapy and rare diseases. The company is focused on building its adeno-associated virus (AAV) therapeutic discov...

Morphotek Inc.

Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology. The company employs its technology to discover and develop optimized antibodies for the treatment of cancer, inflammatory, and infectious diseases. Morphotek currently has two products in clinical development and is positioned to file INDs for additional...

Virtrial

Virtrial is using an award-winning virtual care platform to transform telehealth in the clinical research industry. Virtrial offers a patient management program that combines video, text, and email for clinical trial sites to easily, efficiently, and conveniently address specific patient and/or study needs. The platform can be used on any device and at any...

Cell Therapy Catapult

The Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine. Its vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, making it a location for business start-up and growth. Based in London at Guy's Hospital, the centre takes products into early clinical ...

Harpoon Therapeutics, Inc.

Harpoon Therapeutics is an immuno-oncology company founded by Patrick Baeuerle, Ph.D., a pioneer in the development of T-cell engaging therapies, and MPM Capital. The company is focused on the discovery and development of novel T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics created a novel T-cell recruiting d...

TCA Cellular Therapy, LLC

Under the scientific guidance of cellular biologist, Jose J. Minguell, Ph.D., TCA Cellular Therapy, LLC is a biotherapeutic adult stem cell research and development company. The company has been recognized by the FDA as one of the top 10 U.S. companies researching stem cell therapies. Founded in 2006, the privately-held company is located in Covington, Lou...

U.S. Physical Therapy, Inc.          

Founded in 1990, U.S. Physical Therapy, Inc. operates 418 clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, non-surgical treatment of osteoarthritis, treatment for neurologically-related injuries and rehabilitation of injured workers. In additi...

Therachon

Therachon is developing an innovative therapy for achondroplasia, the leading cause of dwarfism in humans. Therachon’s therapy aims to restore normal bone growth and proportions in children with the disease. For more information visit www.therachon.com.

Atomic International

While our customers and products span the globe we remain a privately held, family-run company totally committed to quality, safety, customer satisfaction and the advancement of accelerator room technology. Today's most advanced cancer therapy centers throughout the world are recognizing the need for state-of-the-art Shieldray® Technology. Leading this movement to modernization, Atomic Interna...

NeoChord

“The 30-patient TACT trial now has numerous patients showing one and even two year durability of repair with clinically significant reductions in mitral regurgitation. Acute procedure success tares in the second half of the trial were 94% with excellent early durability results. These combined results suggest that NeoChord will make a strong contribut...

Proteome Factory AG

The Proteome Factory AG is a modern biotech company specialized in proteomics, protein analysis, target validation and bioinformatics. The proteomic key technology platform significantly increases the chances to identify new drug targets in emerging disease and biomarkers of disease state. Additionally, the finding of biomarkers significantly enhances the opportunities for individual disease treat...

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

Reprieve Cardiovascular, Inc.

Reprieve Cardiovascular’s Guided Diuretic Therapy is designed to manage fluids during diuretic therapy for patients with Acute Decompensated Heart Failure (ADHF), and may relieve a number of symptoms related to this condition. The therapy has the potential to enable precise and predictable management of a patient’s fluid levels, guarding against ...

ClorDiSys Solutions, Inc

ClorDiSys Solutions, Inc. of Lebanon, New Jersey is a company providing years of experience in all aspects of chlorine dioxide technology with a strong background in the Medical Device and pharmaceutical industry operating under GxP. We are a small, flexible, responsive organization with a network of resources to handle any size project. Each project is approached utilizing our strong sterilizatio...

BioTime, Inc. 

BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Company’s current clinical programs are targeting three primary sectors, aesthetics, ophthalmology and cell and drug delivery. Its clinical programs are based on two platform technologies: pluripotent cells...

PharmaVigilant

Based in Westborough, Mass., PharmaVigilant is a SaaS company founded in 2005 to provide broader technologies to streamline the clinical trial process for biotech, pharmaceutical and medical device companies. Its full suite of integrated technology products and services automates the collection, management and analysis of essential documents and clinical t...

Xstrahl

Xstrahl is a leading designer and manufacturer of X-ray systems for use in cancer and dermatology treatments and radiation biology research, providing complete solutions for all X-ray therapy and research applications. Xstrahl has more than 15 years’ experience supporting the X-ray therapy requirements of healthcare providers around the world, from in...

IATEC

Since its foundation, IATEC has focused on delivering high-quality antiviral research across the globe. Clinical trials are becoming increasingly complex; we understand the scientific challenges to be faced during these times, but we also see these challenges as opportunities.To serve our mission even better, IATEC has divided its activities between the IATEC Foundation, IATEC Clinical Trial Servi...

NantCell

NantCell, a member of the NantWorks ecosystem of companies, is a biopharmaceutical company focused on the discovery of innovative molecularly targeted therapies based on the unique molecular profile of the patient's tumor, independent of the cancer's anatomical type. Dr. Patrick Soon-Shiong, the creator of Abraxane® and the founder of the nab® techno...


More From BioPortfolio on "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks